These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 2228020

  • 1. Mechanisms of inhibition of mononuclear cell activation by the iron-chelating agent desferrioxamine.
    Polson RJ, Jenkins R, Lombard M, Williams AC, Roberts S, Nouri-Aria K, Williams R, Bomford A.
    Immunology; 1990 Oct; 71(2):176-81. PubMed ID: 2228020
    [Abstract] [Full Text] [Related]

  • 2. Lymphocyte activation, iron uptake and release by human mononuclear leukocytes in the presence of desferrioxamine.
    Taylor PG, Soyano A, Romano E, Layrisse M.
    Immunopharmacol Immunotoxicol; 1988 Oct; 10(2):165-78. PubMed ID: 3171105
    [Abstract] [Full Text] [Related]

  • 3. Desferoxamine blocks IL 2 receptor expression on human T lymphocytes.
    Carotenuto P, Pontesilli O, Cambier JC, Hayward AR.
    J Immunol; 1986 Apr 01; 136(7):2342-7. PubMed ID: 3005409
    [Abstract] [Full Text] [Related]

  • 4. Effects of benzo[a]pyrene on concanavalin A-stimulated human peripheral blood mononuclear cells in vitro: inhibition of proliferation but no effect on parameters related to the G1 phase of the cell cycle.
    Mudzinski SP.
    Toxicol Appl Pharmacol; 1993 Apr 01; 119(2):166-74. PubMed ID: 8097600
    [Abstract] [Full Text] [Related]

  • 5. Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression.
    Chouaib S, Welte K, Mertelsmann R, Dupont B.
    J Immunol; 1985 Aug 01; 135(2):1172-9. PubMed ID: 2989362
    [Abstract] [Full Text] [Related]

  • 6. Changes in activation markers and cell membrane receptors on human peripheral blood T lymphocytes during cell cycle progression after PHA stimulation.
    Poulton TA, Gallagher A, Potts RC, Beck JS.
    Immunology; 1988 Jul 01; 64(3):419-25. PubMed ID: 3261709
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation.
    Harel-Bellan A, Bertoglio J, Quillet A, Marchiol C, Wakasugi H, Mishall Z, Fradelizi D.
    J Immunol; 1986 Apr 01; 136(7):2463-9. PubMed ID: 3005412
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies.
    Tadmori W, Reed JC, Nowell PC, Kamoun M.
    J Immunol; 1985 Mar 01; 134(3):1709-16. PubMed ID: 2981919
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A soluble factor from Trypanosoma brucei rhodesiense that prevents progression of activated human T lymphocytes through the cell cycle.
    Sztein MB, Kierszenbaum F.
    Immunology; 1991 Jun 01; 73(2):180-5. PubMed ID: 2071163
    [Abstract] [Full Text] [Related]

  • 16. Mechanisms underlying T-lymphocyte activation: mitogen initiates and IL-2 amplifies the expression of transferrin receptors via intracellular iron level.
    Pelosi-Testa E, Samoggia P, Giannella G, Montesoro E, Caravita T, Salvo G, Camagna A, Isacchi G, Testa U, Peschle C.
    Immunology; 1988 Jun 01; 64(2):273-9. PubMed ID: 3134296
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Non-transferrin dependent 59Fe uptake in phytohemagglutinin-stimulated human peripheral lymphocytes.
    Hamazaki S, Glass J.
    Exp Hematol; 1992 May 01; 20(4):436-41. PubMed ID: 1568461
    [Abstract] [Full Text] [Related]

  • 20. The iron metabolism of the human neuroblastoma cell: lack of relationship between the efficacy of iron chelation and the inhibition of DNA synthesis.
    Richardson DR, Ponka P.
    J Lab Clin Med; 1994 Nov 01; 124(5):660-71. PubMed ID: 7964124
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.